Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 323
Selected: 0
NCT IDTitle
NCT05673369Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
NCT05050604A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
NCT04431687A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD-393)
NCT01369472Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule
NCT02651753A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337
NCT02044250Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)
NCT03713892CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects
NCT03849495Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults
NCT05749861A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
NCT02651870Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan Monotherapy
NCT04871646Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314
NCT05571813Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
NCT06695598Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers
NCT04676893Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects
NCT04883658A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2)
NCT01630018Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Trial
NCT01133431The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea
NCT01496261Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial
NCT03431623CKD-11101 Phase 3 SC Study
NCT04694989A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2)
NCT05634447A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391
NCT01071720The Effect of Food on the Pharmacokinetic Characteristics of CKD-501
NCT05719155Pharmacokinetics and Safety/Tolerability of CKD-379
NCT06695572Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers
NCT01685671Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers
NCT03210649Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519
NCT03175835Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects
NCT04322032Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389
NCT02801526Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
NCT03858725Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers
NCT03849287Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adults
NCT02827890CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)
NCT01022671Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previously Treated With Chemotherapy
NCT06974903Retrospective Observational Study on GERD Management in General Hospitals in Korea
NCT07258745Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants
NCT03051841CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma
NCT01501253CKD-828 S-Amlodipine Non-Responder Trial
NCT03726866A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects
NCT04628143A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia
NCT07304726Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers
NCT03770052Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie
NCT02645890Study to Compare the Safety and Pharmacokinetics of CKD-397
NCT05189288Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
NCT01297036Pharmacokinetic Comparisons of Two Donepezil Formulations
NCT02494284Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
NCT03382756A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337
NCT02623868Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.
NCT02484482Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 FDI)
NCT05677438A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
NCT01330563Drug-drug Interaction Study (CKD-501, Ketoconazole)